Global Diabetes Devices Market is Expected to Grow at a CAGR of 6.2%

Diabetes Devices Market

Diabetes Devices Market 2023

The global diabetes devices market size was valued at USD 31.26 Bn in 2023 and is projected to reach USD 63.53 Bn by 2033, exhibiting a CAGR of 6.2%.

NEW YORK,CITY, NEW YORK, UNITED STATES, January 12, 2023 / -- The Global Diabetes Devices Market size was valued at USD 31.26 Bn in 2023 and is projected to reach USD 63.53 Bn by 2033, exhibiting a CAGR of 6.2% during the forecast period. This is due to an increase in diabetes incidence caused by rapid urbanization and sedentary living. The number of diabetes cases worldwide has increased due to technologically advanced, minimally invasive insulin delivery systems. In September 2017, Abbott was approved by the Food and Drug Administration for the FreeStyle Libre Flash Glucose Monitor System. This device attaches a sensor to the upper arm and monitors blood glucose levels.

Diabetes mellitus (sometimes called "diabetes") is a group of metabolic diseases where blood sugar levels remain high. You may notice signs such as frequent trips to the toilet, increased thirst, and a desire to eat more. Long-term dangers include heart disease, stroke, diabetes, chronic kidney disease, and foot ulcers. Nerve damage, eye damage, mental decline, and nerve damage are also possible. Market growth is being driven by diabetes. This can be due to things like aging, obesity, and a poor lifestyle. Obese and overweight people are more likely to develop diabetes. Diabetes is increasing because of risk factors such as being overweight or obese.

View More:

Growth Factors

The primary driver of the global diabetes device market is the rising prevalence of diabetes in the world's population. The demand for diabetes devices is driven by rising obesity rates, increased awareness about diabetes, improved technology in diabetes monitoring, easier availability of diabetes devices, and increasing personal disposable income. Diabetes is on the rise due to obesity and poor eating habits. The growing number of elderly people is also a major reason for diabetes cases.

According to WHO, diabetes was directly responsible for approximately 1.5 million deaths in 2019. High blood sugar levels were responsible for around 2.2 million deaths in 2012. Diabetes can cause blindness, kidney disease, stroke, heart attack, and blindness. The rising awareness of diabetes and its many ill effects encourages people to purchase diabetes devices to monitor their glucose levels and manage it. This is a key factor driving the global growth of the diabetes device market.

Factors driving the decision:

"Introductions of novel and technologically advanced products are driving market growth"

Global innovation in diabetes treatment and monitoring devices is a major driver of global market growth. Tandem Diabetes Care, Inc. received FDA approval in February 2019 for marketing its first insulin pump that uses interoperable technology. The t:SlimX2 insulin pump was the first device to have been classified under a new premarket review process. In January 2019, Bigfoot Biomedical formed a partnership to Eli Lilly and Company to develop solutions that optimize insulin delivery and dosing using artificial intelligence.

"Globally, rising prevalence of diabetes is fueling the demand for monitoring and treatment devices"

Globally, diabetes is on the rise, particularly in developing countries like India and China. Rapid urbanization and sedentary lifestyle growth, particularly in developing countries, are two of the reasons for diabetes's rapid rise in prevalence. According to the International Diabetes Federation, around 425 million people were living with diabetes in 2017. This number is expected to rise to around 625 million by 2045. These studies show that China, India and Brazil account for between 55.0%-60.0% of global diabetes populations.

Purchase the report @

The Key Market Segments


Blood Glucose Meters

Test Strips for Blood Glucose

Insulin pumps

Insulin Syringes


Medical Care

Personal Care

The report includes key market players:


Medtronic plc



Ascensia Diabetes Treatment




B. Braun

Terumo Corporation






The Key Developments

Labcorp OnDemand is an at-home hemoglobin measurement device that measures hemoglobin A1c from small blood samples. It was launched by Labcorp in May 2022. Labcorp's OnDemand Diabetes Risk Test uses dried blood technology to determine average blood sugar levels over time. Consumers can monitor their health status from their homes by simply taking a few drops of blood and a finger prick.

Tandem Diabetes Care, Inc. introduced the slim X2 insulin pump in January 2020 with Control-IQ technology. This device features a hybrid-closed loop feature that increases the range of the insulin pump (70-180 mg/dL).

Roche Diabetes Care India introduced Accu-Chek in May 2019. This is a diabetic blood monitoring device. The'mySugr’ app is aimed at improving the lives of people with diabetes.

Our Reports:

Global Clinical Trial Management (CTM) Market Share, Growth, Trends, and Forecast to 2033:

Global Intelligent Completion Market Analysis By Top Industry Players, Trends And Forecast Upto 2033

Global Flashing Beacon Buoys Market Industry Trends and Analysis-2033

Global Congress Tourism Market Analysis, Industry Outlook, and Growth Forecast 2033

Global Long Flashing Beacon Buoys Market To Witness A Powerful Development Through The Forecast Interval 2023-2033 To 2033

Global Lubricating Oil Additive Market 2023-2033 Finest Workable Technique That Will Assist To Increase Your Enterprise Income By 2033

Communication contact:

Global Business Development Teams - (Powered By Prudour Pvt. Ltd.)
Send Email:
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Tel: +1 718 618 4351

Tajammul Pangarkar
Prudour Pvt Lmt
+1 857-445-0045
email us here
Visit us on social media: